Is HbA1c a valid and feasible tool for the diagnosis of diabetes?

Diabetes Research and Clinical Practice

Volumn 93, Issue 3, 2011, Pages 314-316

  Kowall, B ^a   Rathmann, W ^a   Landgraf, R ^b  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b German Diabetes Foundation   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ALGORITHM; BLOOD GLUCOSE MONITORING; CLINICAL RESEARCH; DIABETES MELLITUS; EARLY DIAGNOSIS; EPIDEMIOLOGICAL DATA; FEASIBILITY STUDY; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INTERVENTION STUDY; LIFESTYLE MODIFICATION; MORTALITY; NOTE; PRACTICE GUIDELINE; PREVALENCE; RISK FACTOR; VALIDITY;

ALGORITHMS; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS;

EID: 80052710226     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.06.024     Document Type: Note

References (21)

1. Consensus Committee Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007, 30:2399-2400.
2. International Expert Committee International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334.
3. American Diabetes Association Standards of medical care in diabetes - 2010. Diabetes Care 2010, 33:S11-S61.
4. WHO Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation. Diabetes Res Clin Pract 2011, 93:299-309.
5. Bloomgarden Z.T. A1C: recommendations, debates, and questions. Diabetes Care 2009, 32:e141-e147.
6. Kilpatrick E., Bloomgarden Z., Zimmet P. Is haemoglobin A1c a step forward for diagnosing diabetes?. BMJ 2009, 339:1288-1290.
7. Pani L.N., Korenda L., Meigs J.B., Driver C., Chamany S., Fox C.S., et al. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 2008, 31:1991-1996.
8. Herman W.H., Ma Y., Uwaifo G., Haffner S., Kahn S.E., Horton E.S., et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007, 30:2453-2457.
9. Snieder H., Sawtell P.A., Ross L., Walker J., Spector T.D., Leslie R.D.G. HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes 2001, 50:2858-2863.
10. Report of a WHO/IDF consultation Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia 2006, WHO, Geneva.
11. Christensen D.L., Witte D.R., Kaduka L., Jørgensen M.E., Borch-Johnsen K., Mohan V., et al. Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care 2010, 33:580-582.
12. Rathmann W., Kowall B., Tamayo T., Giani G., Holle R., Thorand B., et al. Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: the KORA S4/F4 Study. Ann Med 2010, (November). (Epub ahead of print).
13. Carson A.P., Reynolds K., Fonseca V.A., Muntner P. Comparison of A1c and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care 2010, 33:95-97.
14. Lorenzo C., Haffner S.M. Performance characteristics of the new definition of diabetes. The Insulin Resistance Atherosclerosis Study. Diabetes Care 2010, 33:335-337.
15. Bao Y., Ma X., Li H., Zhou M., Hu C., Wu H., et al. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ 2010, 340:c2249. 10.1136/bmj.c2249.
16. Selvin E., Steffes M.W., Zhu H., Matsushita K., Wagenknecht L., Pankow J., et al. Glycated hemoglobin, diabetes, and cardiovascular risk in non-diabetic adults. New Engl J Med 2010, 362:800-811.
17. Khaw K.T., Wareham N., Luben R., Bingham S., Oakes S., Welch A., et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 2001, 322:15.
18. Colagiuri S., Lee C.M., Wong T.Y., Balkau B., Shaw J.E., Borch-Johnsen K., et al. Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care 2011, 34:145-150.
19. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl J Med 2002, 346:393-403.
20. Tuomilehto J., Lindström J., Eriksson J.G., Valle T.T., Hämäläinen H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New Engl J Med 2001, 344:1343-1350.
21. The DECODE Study Group Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003, 26:61-69.